Emanuela Caci

965 total citations
20 papers, 795 citations indexed

About

Emanuela Caci is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Emanuela Caci has authored 20 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Emanuela Caci's work include Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (7 papers) and Asthma and respiratory diseases (5 papers). Emanuela Caci is often cited by papers focused on Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (7 papers) and Asthma and respiratory diseases (5 papers). Emanuela Caci collaborates with scholars based in Italy, Spain and France. Emanuela Caci's co-authors include Luis J. V. Galietta, Olga Zegarra‐Moran, Roberto Ravazzolo, Nicoletta Pedemonte, Elvira Sondo, Antonella Caputo, Ambra Gianotti, Chiara Folli, Valeria Tomati and Andrea Armirotti and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Emanuela Caci

19 papers receiving 785 citations

Peers

Emanuela Caci
William R. Thelin United States
Tony J. Savage United Kingdom
Nathalie Schmid United States
Elizabeth L. Kramer United States
Janet E. Simpson United States
Emanuela Caci
Citations per year, relative to Emanuela Caci Emanuela Caci (= 1×) peers Elizabeth A. Cowley

Countries citing papers authored by Emanuela Caci

Since Specialization
Citations

This map shows the geographic impact of Emanuela Caci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Caci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Caci more than expected).

Fields of papers citing papers by Emanuela Caci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Caci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Caci. The network helps show where Emanuela Caci may publish in the future.

Co-authorship network of co-authors of Emanuela Caci

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Caci. A scholar is included among the top collaborators of Emanuela Caci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Caci. Emanuela Caci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gianotti, Ambra, Valeria Capurro, María García‐Valverde, et al.. (2020). Small Molecule Anion Carriers Correct Abnormal Airway Surface Liquid Properties in Cystic Fibrosis Airway Epithelia. International Journal of Molecular Sciences. 21(4). 1488–1488. 26 indexed citations
2.
Fiore, Michele, Valeria Capurro, Cristiana Picco, et al.. (2019). Small molecule‐facilitated anion transporters in cells for a novel therapeutic approach to cystic fibrosis. British Journal of Pharmacology. 176(11). 1764–1779. 30 indexed citations
3.
Sondo, Elvira, Federico Falchi, Emanuela Caci, et al.. (2018). Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia. Cell chemical biology. 25(7). 891–905.e8. 50 indexed citations
4.
Tomati, Valeria, Emanuela Caci, Loretta Ferrera, et al.. (2018). Thymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia. JCI Insight. 3(3). 20 indexed citations
5.
Gianotti, Ambra, et al.. (2018). In vitro Methods for the Development and Analysis of Human Primary Airway Epithelia. Frontiers in Pharmacology. 9. 1176–1176. 32 indexed citations
6.
Fiore, Michele, Debora Baroni, Valeria Capurro, et al.. (2018). Anion-Transport Mechanism of a Triazole-Bearing Derivative of Prodigiosine: A Candidate for Cystic Fibrosis Therapy. Frontiers in Pharmacology. 9. 852–852. 25 indexed citations
7.
Braccia, Clarissa, Valeria Tomati, Emanuela Caci, Nicoletta Pedemonte, & Andrea Armirotti. (2018). SWATH label-free proteomics for cystic fibrosis research. Journal of Cystic Fibrosis. 18(4). 501–506. 15 indexed citations
8.
Chiappori, Alessandra, Chiara Folli, Emanuela Caci, et al.. (2016). CD4+CD25highCD127- regulatory T-cells in COPD: smoke and drugs effect. World Allergy Organization Journal. 9. 5–5. 27 indexed citations
9.
Gianotti, Ambra, Loretta Ferrera, Emanuela Caci, et al.. (2016). Pharmacological analysis of epithelial chloride secretion mechanisms in adult murine airways. European Journal of Pharmacology. 781. 100–108. 21 indexed citations
10.
Gianotti, Ambra, Emanuela Caci, Elvira Sondo, et al.. (2013). Epithelial Sodium Channel Silencing as a Strategy to Correct the Airway Surface Fluid Deficit in Cystic Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 49(3). 445–452. 24 indexed citations
11.
Pedemonte, Nicoletta, Valeria Tomati, Elvira Sondo, et al.. (2011). Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations. Journal of Biological Chemistry. 286(17). 15215–15226. 50 indexed citations
12.
Airoldi, Irma, Emma Di Carlo, Claudia Cocco, et al.. (2009). IL-12 Can Target Human Lung Adenocarcinoma Cells and Normal Bronchial Epithelial Cells Surrounding Tumor Lesions. PLoS ONE. 4(7). e6119–e6119. 34 indexed citations
13.
Caputo, Antonella, Alexandre Hinzpeter, Emanuela Caci, et al.. (2009). Mutation-Specific Potency and Efficacy of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Potentiators. Journal of Pharmacology and Experimental Therapeutics. 330(3). 783–791. 27 indexed citations
14.
Caci, Emanuela, Antonella Caputo, Alexandre Hinzpeter, et al.. (2008). Evidence for direct CFTR inhibition by CFTRinh-172 based on Arg347 mutagenesis. Biochemical Journal. 413(1). 135–142. 88 indexed citations
15.
Pedemonte, Nicoletta, Emanuela Caci, Elvira Sondo, et al.. (2007). Thiocyanate Transport in Resting and IL-4-Stimulated Human Bronchial Epithelial Cells: Role of Pendrin and Anion Channels. The Journal of Immunology. 178(8). 5144–5153. 119 indexed citations
16.
Caci, Emanuela, et al.. (2006). Valutazione del ruolo dell’HPV-DNA test nei programmi di prevenzione del cancro cervicale. Microbiologia medica. 21(4).
17.
Candiano, Giovanni, Maurizio Bruschi, Nicoletta Pedemonte, et al.. (2005). Gelsolin Secretion in Interleukin-4–treated Bronchial Epithelia and in Asthmatic Airways. American Journal of Respiratory and Critical Care Medicine. 172(9). 1090–1096. 36 indexed citations
18.
Pedemonte, Nicoletta, Emanuela Caci, Mauro Mazzei, et al.. (2005). Antihypertensive 1,4-Dihydropyridines as Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator Channel Gating Defect Caused by Cystic Fibrosis Mutations. Molecular Pharmacology. 68(6). 1736–1746. 46 indexed citations
19.
Mazzei, Mauro, et al.. (2003). 2-(Dialkylamino)-4H-1-benzopyran-4-one derivatives modify chloride conductance in CFTR expressing cells. Il Farmaco. 58(9). 961–970. 4 indexed citations
20.
Galietta, Luis J. V., Patrick Pagésy, Chiara Folli, et al.. (2002). IL-4 Is a Potent Modulator of Ion Transport in the Human Bronchial Epithelium In Vitro. The Journal of Immunology. 168(2). 839–845. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026